Search

Your search keyword '"AIDS vaccines -- Health aspects"' showing total 1,160 results
Start Over Descriptor "AIDS vaccines -- Health aspects"
1,160 results on '"AIDS vaccines -- Health aspects"'

2. HIV vaccines tested in PrEPVacc fail to reduce infections

Subjects
HIV (Viruses) -- Prevention, Vaccination -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Medical tests -- Health aspects, HIV testing -- Health aspects, Infection -- Prevention, AIDS vaccines -- Health aspects, HIV infection -- Prevention, Business, Health, Health care industry, Prevention, Health aspects
Abstract

2024 AUG 11 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- The results of the PrEPVacc HIV vaccine trial conducted in [...]

Published
2024

3. Researchers from Pasteur Institute Iran Detail Findings in HIV/AIDS (Engineered Clearcoli Tm-derived Outer Membrane Vesicles As Functional Carriers for Development of Hiv-1 Therapeutic Vaccine Candidate)

Subjects
HIV (Viruses) -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Antigens -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology, Health aspects
Abstract

2024 AUG 5 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Researchers detail new data in Immune System Diseases and Conditions - HIV/AIDS. According to [...]

Published
2024

4. Is There an HIV Vaccine?

Author

Fiorillo, Steve

Subjects
United States. National Institute of Allergy and Infectious Diseases, HIV (Viruses) -- Prevention, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, B cells -- Health aspects, HIV patients -- Health aspects, AIDS vaccines -- Health aspects, Health
Abstract

On May 18, 2023, the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) observes HIV Vaccine Day to promote awareness and education of HIV vaccine research [...]

Published
2023

5. Antibody response against SARS-CoV-2 spike protein in people with HIV after COVID-19 vaccination

Subjects
HIV (Viruses) -- Health aspects, HIV patients -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2024 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2024

6. Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus

Author

Dorhoi, Anca, Kotze, Leigh A., Berzofsky, Jay A., Sui, Yongjun, Gabrilovich, Dmitry I., Garg, Ankita, Hafner, Richard, Khader, Shabaana A., Schaible, Ulrich E., Kaufmann, Stefan H.E., Walzl, Gerhard, Lutz, Manfred B., Mahon, Robert N., Ostrand-Rosenberg, Suzanne, Bishai, William, and Plessis, Nelita du

Subjects
AIDS vaccines -- Health aspects, AIDS (Disease) -- Health aspects, Vaccination -- Health aspects, Carboplatin -- Health aspects, Nilotinib -- Health aspects, Tuberculosis -- Health aspects, Antineoplastic agents -- Health aspects, Health care industry
Abstract

The critical role of suppressive myeloid cells in immune regulation has come to the forefront in cancer research, with myeloid-derived suppressor cells (MDSCs) as a main oncology immunotherapeutic target. Recent improvement and standardization of criteria classifying tumor-induced MDSCs have led to unified descriptions and also promoted MDSC research in tuberculosis (TB) and AIDS. Despite convincing evidence on the induction of MDSCs by pathogen-derived molecules and inflammatory mediators in TB and AIDS, very little attention has been given to their therapeutic modulation or roles in vaccination in these diseases. Clinical manifestations in TB are consequences of complex host- pathogen interactions and are substantially affected by HIV infection. Here we summarize the current understanding and knowledge gaps regarding the role of MDSCs in HIV and Mycobacterium tuberculosis (co)infections. We discuss key scientific priorities to enable application of this knowledge to the development of novel strategies to improve vaccine efficacy and/or implementation of enhanced treatment approaches. Building on recent findings and potential for cross-fertilization between oncology and infection biology, we highlight current challenges and untapped opportunities for translating new advances in MDSC research into clinical applications for TB and AIDS., Innate suppressor cells in cancer, tuberculosis, and AIDS Immunosuppressive myeloid cells were originally described in tumor-bearing mice (1) and cancer patients (2) as pathologically activated or atypical myeloid cells. As [...]

Published
2020
Full Text
View/download PDF

7. South Africa: Africa's First HIV Vaccine Trial Fails

Subjects
HIV (Viruses) -- Health aspects, Vaccination -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Clinical trials -- Health aspects, AIDS vaccines -- Health aspects, News, opinion and commentary
Abstract

Byline: Jerry Chifamba Harare -- An experimental HIV vaccine trial conducted in South Africa, Tanzania, and Uganda was prematurely terminated due to preliminary findings indicating the vaccine would not be [...]

Published
2023

8. HIV vaccine trial in Africa halted after disappointing data

Subjects
HIV (Viruses) -- Prevention, Clinical trials -- Health aspects, AIDS vaccines -- Health aspects, Business, international
Abstract

A trial of an experimental HIV vaccine in Uganda, Tanzania and South Africa has been stopped early after preliminary data suggested it would not be effective in preventing infection, according [...]

Published
2023

9. NATURE-INSPIRED PROPHYLACTIC LUBRICANTS AGAINST HIV-1 AND HSV-2

Subjects
HIV (Viruses) -- Drug therapy, Lubrication and lubricants -- Health aspects, AIDS vaccines -- Health aspects, Lubricants industry -- Health aspects, Business, international, European Union
Abstract

Nature-Inspired Prophylactic Lubricants Against Hiv-1 And Hsv-2 Currently, there are no vaccines against HIV (human immunodeficiency virus) and HSV (herpes simplex virus) infections. Condom, when used properly, are the most [...]

Published
2023

10. Improving Safety of the Blood Supply from Transmission of HIV/AIDS and Other Emerging Blood Borne Viral and Biodefense Agents by Developing Sensitive Diagnostic Tools and Investigating Disease Pathogenesis

Subjects
HIV (Viruses) -- Development and progression, Bioterrorism -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, HIV testing -- Health aspects, B cells -- Health aspects, Infection -- Development and progression, Biological weapons -- Health aspects, Blood banks -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2024 APR 8 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Principal Investigator: Indira Hewlett, PhD Office / Division / Lab: OBRR / DETTD / [...]

Published
2024

11. Dynamics of T cell responses to COVID-19 vaccines and breakthrough infection in people living with HIV receiving antiretroviral therapy

Subjects
HIV (Viruses) -- Drug therapy, T cells -- Health aspects, Highly active antiretroviral therapy -- Health aspects, HIV patients -- Drug therapy, Disease susceptibility -- Drug therapy, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2024 MAR 25 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2024

12. DNA particles that mimic viruses hold promise as vaccines

Subjects
Viral antigens -- Health aspects, DNA -- Health aspects, Genetic research -- Health aspects, B cells -- Health aspects, Proteins -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2024 FEB 12 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon [...]

Published
2024

13. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

Author

Neidich, Scott D., Fong, Youyi, Li, Shuying S., Geraghty, Daniel E., Williamson, Brian D., Young, William Chad, Goodman, Derrick, Seaton, Kelly E., Shen, Xiaoying, Sawant, Sheetal, Zhang, Lu, deCamp, Allan C., Blette, Bryan S., Shao, Mengshu, Yates, Nicole L., Feely, Frederick, Pyo, Chul-Woo, Ferrari, Guido, Frank, Ian, Karuna, Shelly T., Swann, Edith M., Mascola, John R., Graham, Barney S., Hammer, Scott M., Sobieszczyk, Magdalena E., Corey, Lawrence, Janes, Holly E., McElrath, M. Juliana, Gottardo, Raphael, Gilbert, Peter B., and Tomaras, Georgia D.

Subjects
Antigens -- Health aspects, AIDS vaccines -- Health aspects, Single nucleotide polymorphisms -- Health aspects, Immunoglobulin A -- Health aspects, HIV -- Risk factors -- Health aspects, Immunoglobulin G -- Health aspects, Adenoviruses -- Health aspects, Vaccines, Clinical trials, Genetic polymorphisms, DNA, Antibodies, Transgender people, Health care industry, Duke University
Abstract

HVTN 505 is a preventative vaccine efficacy trial testing DNA followed by recombinant adenovirus serotype 5 (rAd5) in circumcised, Ad5-seronegative men and transgendered persons who have sex with men in the United States. Identified immune correlates of lower HIV-1 risk and a virus sieve analysis revealed that, despite lacking overall efficacy, vaccine-elicited responses exerted pressure on infecting HIV-1 viruses. To interrogate the mechanism of the antibody correlate of HIV-1 risk, we examined antigen-specific antibody recruitment of Fc[gamma] receptors (Fc[gamma]Rs), antibody-dependent cellular phagocytosis (ADCP), and the role of anti-envelope (anti-Env) IgG3. In a prespecified immune correlates analysis, antibody-dependent monocyte phagocytosis and antibody binding to Fc[gamma]RIIa correlated with decreased HIV-1 risk. Follow-up analyses revealed that anti-Env IgG3 breadth correlated with reduced HIV-1 risk, anti-Env IgA negatively modified infection risk by Fc effector functions, and that vaccine recipients with a specific Fc[gamma]RIIa single-nucleotide polymorphism locus had a stronger correlation with decreased HIV-1 risk when ADCP, Env-Fc[gamma]RIIa, and IgG3 binding were high. Additionally, Fc[gamma]RIIa engagement correlated with decreased viral load setpoint in vaccine recipients who acquired HIV-1. These data support a role for vaccine-elicited anti-HIV-1 Env IgG3, antibody engagement of FcRs, and phagocytosis as potential mechanisms for HIV-1 prevention., Introduction An efficacious vaccine that provides durable immunity remains a key priority in the fight against HIV-1. One strategy to identify an efficacious vaccine regimen is the identification of immune [...]

Published
2019
Full Text
View/download PDF

14. European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

Subjects
HIV (Viruses) -- Health aspects, AIDS vaccines -- Health aspects, Business, international, European Union
Abstract

European Hiv Vaccine Alliance (Ehva): A Eu Platform For The Discovery And Evaluation Of Novel Prophylactic And Therapeutic Vaccine Candidates Funded Under Societal Challenges - Health, Demographic Change And Well-Being [...]

Published
2023

15. Priming, shaping and polishing: In search of a HIV vaccine

Subjects
HIV (Viruses) -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Tuberculosis -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2024 JAN 29 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Worldwide, an estimated, 40 million people live with HIV. Two-thirds of this group on [...]

Published
2024

16. Reports from Karolinska University Hospital Advance Knowledge in COVID-19 (Mait Cell Compartment Characteristics Are Associated With the Immune Response Magnitude To the Bnt162b2 Mrna Anti-sars-cov-2 Vaccine)

Subjects
Cell Press, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, T cells -- Health aspects, Messenger RNA -- Health aspects, Periodical publishing -- Health aspects, AIDS vaccines -- Health aspects, Coronaviruses -- Health aspects, Virus diseases -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology, Comirnaty (Vaccine) -- Health aspects
Abstract

2023 DEC 11 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Researchers detail new data in Coronavirus - COVID-19. According to news reporting from Stockholm, [...]

Published
2023

17. Germany : International vaccine initiative CEPI promotes the establishment of a 'vaccine library' to prevent future pandemics

Subjects
Epidemics -- Germany, Climatic changes -- Health aspects, AIDS vaccines -- Health aspects, Business, international, Coalition for Epidemic Preparedness Innovations
Abstract

The international 'Coalition for Epidemic Preparedness Innovations' (CEPI) is funding computer-aided vaccine development at the University of Leipzig with EUR 1.77 million with the aim of building a digital 'vaccine [...]

Published
2023

18. Experimental mRNA HIV vaccine safe, shows promise in animals

Subjects
United States. National Institutes of Health, United States. National Institute of Allergy and Infectious Diseases, HIV (Viruses) -- Health aspects, Messenger RNA -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries
Abstract

An experimental HIV vaccine based on mRNA--the same platform technology used in two highly effective Covid-19 vaccines--shows promise in mice and non-human primates, according to scientists at the National Institute [...]

Published
2021

19. Challenges in optimizing preexposure prophylaxis development, engagement, and access for HIV prevention

Author

Scully, Eileen P., Weld, Ethel D., and Blankson, Joel N.

Subjects
Prophylaxis -- Health aspects, AIDS vaccines -- Health aspects, Highly active antiretroviral therapy -- Health aspects, HIV -- Prevention -- Control -- Health aspects, Infection -- Prevention -- Health aspects, Antiretroviral agents -- Health aspects, Sexually transmitted disease prevention -- Health aspects, Vaccines, Health care industry
Abstract

One of the greatest successes of modern science is the development of effective antiretroviral therapy (ART) for control of HIV-1 infection. Arguably one of the more innovative responses to the [...]

Published
2019
Full Text
View/download PDF

20. Striking a balance in an antibody network: A roadmap for HIV-1 vaccines

Author

Charles, Tysheena P. and Derdeyn, Cynthia A.

Subjects
AIDS vaccines -- Health aspects, HIV -- Health aspects, Immunoglobulin A -- Health aspects, Infection -- Health aspects, Immunoglobulin G -- Health aspects, Vaccines, Clinical trials, Health care industry
Abstract

With almost 2 million new HIV-1 infections in 2018, a highly effective vaccine is imperative. Vaccine-elicited HIV-1 antibodies contribute to protection through multiple nonneutralizing activities, but the exact mechanisms remain unknown. In this issue of the JCI, Neidich and associates sought to determine how antibodies contributed to reducing the risk of HIV-1 acquisition in a phase IIb preventative vaccine efficacy trial, HVTN 505. Their studies revealed that antibody-dependent cellular phagocytosis (ADCP) and Fc[gamma]RIIa binding were strongly associated with reduced HIV-1 risk; however, HIV-1 envelope-specific IgG3, IgA; and host Fc[gamma]RIIa genotype also influenced risk. This study highlights the intricate interactions between antibodies and innate immune functions in humans., Antibody Fc interactions correlated with reduced HIV-1 acquisition HIV-1 remains the leading cause of death worldwide, with 38 million people living with HIV/AIDS and 770,000 HIV-infected people dying in 2018 [...]

Published
2019
Full Text
View/download PDF

21. TB vaccine discovery paves path to end no. 1 killer of people living with HIV

Subjects
HIV (Viruses) -- Prevention, BCG vaccines -- Health aspects, BCG -- Health aspects, Antitubercular agents -- Health aspects, Tuberculosis vaccines -- Health aspects, Tuberculosis -- Prevention, Medical colleges -- Health aspects, HIV patients -- Health aspects, Primates -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2023 OCT 23 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Scientists at the University of Pittsburgh School of Medicine have discovered a tuberculosis (TB) [...]

Published
2023

22. Studies Conducted at University of the Witwatersrand on HIV/AIDS Recently Reported [T-cell Responses Induced By Chadox1 Ncov-19 (Azd1222) Vaccine To Wild-type Severe Acute Respiratory Syndrome Coronavirus 2 Among People With and Without Hiv In ...]

Subjects
HIV (Viruses) -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, T cells -- Health aspects, Coronaviruses -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology, University of the Witwatersrand, AZD1222 (Vaccine) -- Health aspects
Abstract

2023 SEP 18 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Investigators publish new report on Immune System Diseases and Conditions - HIV/AIDS. According to [...]

Published
2023

23. Ogren: Crossing the placenta to block HIV, Zika

Author

Ritter, Mary Ellen

Subjects
HIV (Viruses) -- Health aspects, Viral antibodies -- Health aspects, Infection -- Health aspects, RNA -- Health aspects, Antibodies -- Health aspects, AIDS vaccines -- Health aspects, News, opinion and commentary, Sports and fitness
Abstract

Byline: Mary Ellen Ritter A Cell study published last week showed the antibodies created by RNA vaccines for HIV and Zika virus can cross the placental barrier and inoculate baby [...]

Published
2023

24. CREATING A VERSATILE VACCINE TO TAKE ON COVID-19 IN ITS MANY GUISES

Subjects
Machine learning -- Health aspects, AIDS vaccines -- Health aspects, News, opinion and commentary, Massachusetts Institute of Technology
Abstract

CAMBRIDGE, Mass. -- The following information was released by the Massachusetts Institute of Technology (MIT): Aided by machine learning, scientists are working to develop a vaccine that would be effective [...]

Published
2023

25. HIV Vaccine Research Set to Change Focus in Wake of Mosaico Disappointment

Subjects
Johnson & Johnson, HIV (Viruses) -- Prevention, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Infection -- Prevention, AIDS vaccines -- Health aspects, Pharmaceutical industry -- Health aspects, HIV infection -- Prevention, News, opinion and commentary
Abstract

Byline: Adele Baleta Hopes for the Johnson & Johnson (J&J) Mosaico vaccine - the only HIV vaccine candidate in late-stage (Phase 3) clinical trials - were dashed with manufacturer Janssen [...]

Published
2023

26. More evidence COVID vaccines work well for people with HIV

Subjects
Pfizer Inc., HIV (Viruses) -- Control -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, T cells -- Health aspects, Antiviral agents -- Health aspects, Highly active antiretroviral therapy -- Health aspects, B cells -- Health aspects, HIV patients -- Health aspects, AIDS treatment -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceutical industry -- Health aspects, Business, international
Abstract

Brussels: European AIDS Treatment Group has issued the following press release: People living with HIV generally respond well to COVID-19 vaccines--especially if they receive booster shots--thereby dramatically reducing their risk [...]

Published
2023

27. Reports on HIV/AIDS Findings from University of California San Francisco (UCSF) Provide New Insights (Prevention, Treatment and Cure of Hiv Infection)

Subjects
HIV (Viruses) -- Drug therapy -- Prevention, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Sexually transmitted diseases -- Prevention, AIDS vaccines -- Health aspects, HIV infection -- Drug therapy -- Prevention, Pharmaceuticals and cosmetics industries, Health, Science and technology, University of California
Abstract

2023 JUL 24 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- A new study on Immune System Diseases and Conditions - HIV/AIDS is now available. [...]

Published
2023

28. Findings in HIV/AIDS Reported from Walter Sisulu University (Prevalence of Hepatitis-b Virus Co-infection Among People Living With Hiv In Mthatha Region of South Africa)

Subjects
HIV (Viruses) -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Infection -- Health aspects, Hepatitis B -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2023 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Current study results on Immune System Diseases and Conditions - HIV/AIDS have been published. [...]

Published
2023

29. Reduction in the risk of mpox infection after MVA-BN vaccination in individuals on HIV pre-exposure prophylaxis: a Spanish cohort study

Subjects
HIV (Viruses) -- Risk factors, Vaccination -- Health aspects, Medical records -- Health aspects, Infection -- Risk factors, AIDS (Disease) -- Risk factors, AIDS vaccines -- Health aspects, Smallpox vaccine -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2023 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2023

30. Ukraine : The Ministry of Health provides an opportunity and encourages citizens to get vaccinated against SARS

Subjects
Sanofi S.A., Vaccination -- Health aspects, Influenza vaccines -- Health aspects, Influenza -- Health aspects, Humanitarian aid -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceutical industry -- Health aspects, Business, international
Abstract

Despite Russian aggression against Ukraine, the Ministry of Health is working to provide Ukrainians with vaccines. This year, as humanitarian aid, Ukraine received 223,000 doses of influenza vaccines (60,000 doses [...]

Published
2022

31. Ukraine : UNICEF provided Ukraine with vaccines against tuberculosis, diphtheria, tetanus, whooping cough, hepatitis B and HIV infection

Subjects
Diphtheria -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Infants -- Health aspects, Tuberculosis -- Health aspects, AIDS vaccines -- Health aspects, Tetanus -- Health aspects, HIV (Viruses) -- Health aspects, Vaccination -- Health aspects, Tuberculosis vaccines -- Health aspects, Antitubercular agents -- Health aspects, Hepatitis B -- Health aspects, Whooping-cough -- Health aspects, HIV infection -- Health aspects, Business, international, United Nations. Children's Fund
Abstract

The United Nations Children's Fund (UNICEF) delivered 190,000 doses of the BCG vaccine against tuberculosis to Ukraine, as well as 60,000 doses of the combined vaccine for the prevention of [...]

Published
2022

32. UK analysis shows one dose of monkeypox vaccine yields strong protection

Subjects
Human monkeypox -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Vaccination -- Health aspects, Infection -- Health aspects, AIDS vaccines -- Health aspects, Business, international
Abstract

Brussels: European AIDS Treatment Group has issued the following press release: An analysis released Tuesday by U.K. health officials indicates that even one dose of the monkeypox vaccine provides strong [...]

Published
2022

33. New COVID-19 Findings from University of the Witwatersrand Described [Durability of Chadox1 Ncov-19 (Azd1222) Vaccine and Hybrid Humoral Immunity Against Variants Including Omicron Ba.1 and Ba.4 6 Months After Vaccination (Cov005): a Post-hoc ...]

Subjects
Vaccination -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, AIDS vaccines -- Health aspects, Coronaviruses -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology, University of the Witwatersrand, South African Medical Research Council, AZD1222 (Vaccine) -- Health aspects
Abstract

2023 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- New research on Coronavirus - COVID-19 is the subject of a report. According to [...]

Published
2023

34. Studies from GlaxoSmithKline plc Have Provided New Information about HIV/AIDS (Expert Perspectives On the Vaccination of Individuals Who Are At Increased Risk of Meningococcal Disease Due To Medical Conditions: a Podcast)

Subjects
United States. Centers for Disease Control and Prevention, GSK PLC, Podcasting -- Health aspects, Meningitis -- Risk factors -- Prevention, Sickle cell anemia -- Prevention -- Risk factors, Vaccination -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceutical industry -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2023 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Researchers detail new data in Immune System Diseases and Conditions - HIV/AIDS. According to [...]

Published
2023

35. Researchers at Statens Serum Institute Have Reported New Data on COVID-19 (Outcomes Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Individuals With and Without Hiv In Denmark)

Subjects
HIV (Viruses) -- Health aspects, Vaccination -- Health aspects, Coronaviruses -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2023 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Fresh data on Coronavirus - COVID-19 are presented in a new report. According to [...]

Published
2023

36. Data on HIV/AIDS Discussed by Researchers at University of St Andrews (Estimating the Global Impact of Coronavirus Disease 2019 On People Living With Hiv)

Subjects
HIV (Viruses) -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, HIV patients -- Health aspects, Coronaviruses -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2023 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- New research on Immune System Diseases and Conditions - HIV/AIDS is the subject of [...]

Published
2023

37. DelSiTech Awarded a Grant to Develop Controlled and Sustained Release Injectables for Prophylactic HIV Vaccine

Subjects
HIV (Viruses) -- Control -- Health aspects, Drugs -- Vehicles, B cells -- Health aspects, AIDS (Disease) -- Health aspects -- Control, Drug delivery systems -- Health aspects, AIDS vaccines -- Health aspects, Company financing, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2023 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- DelSiTech Ltd, a Finnish drug delivery and drug development company, announces that it has [...]

Published
2023

38. New vaccine targets life-threatening fungal infections, a growing health concern

Subjects
Diseases -- Health aspects, Drug resistance -- Health aspects, Antifungal agents -- Health aspects, Drug approval -- Health aspects, AIDS (Disease) -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology, University of Georgia
Abstract

2023 FEB 13 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- A new vaccine from the University of Georgia could be the first clinically approved [...]

Published
2023

39. Investigators from Pasteur Institute Iran Release New Data on HIV/AIDS (Ll-37 Antimicrobial Peptide and Heterologous Prime-boost Vaccination Regimen Significantly Induce Hiv-1 Nef-vpr Antigen- and Virion-specific Immune Responses In Mice)

Subjects
HIV (Viruses) -- Drug therapy, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Vaccination -- Health aspects, Immune response -- Health aspects, Highly active antiretroviral therapy -- Health aspects, Antigens -- Health aspects, Peptides -- Health aspects, AIDS vaccines -- Health aspects, HIV infection -- Drug therapy, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2023 FEB 13 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- New research on Immune System Diseases and Conditions - HIV/AIDS is the subject of [...]

Published
2023

40. Data from Duke University Provide New Insights into HIV/AIDS (Stabilized Hiv-1 Envelope Immunization Induces Neutralizing Antibodies To the Cd4bs and Protects Macaques Against Mucosal Infection)

Subjects
HIV (Viruses) -- Health aspects, Immunization -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology, Duke University
Abstract

2023 FEB 13 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Fresh data on Immune System Diseases and Conditions - HIV/AIDS are presented in a [...]

Published
2023

41. AHF: Monkeypox Vaccine Access Must Be Guided by Global Equity, Inclusion

Subjects
The Associated Press, Human monkeypox -- Health aspects, Public health -- Health aspects, AIDS vaccines -- Health aspects, Business, Business, international, World Health Organization
Abstract

Associated Press reports that while 'O countries including Britain, Canada, Germany and the U.S. have ordered millions of (monkeypox) vaccine doses, none has gone to Africa.' After more than two [...]

Published
2022

42. Nigeria: Keeping Hope Alive - Waiting for an HIV Vaccine

Subjects
HIV (Viruses) -- Prevention, Capital punishment -- Health aspects, Infection -- Prevention, Physical fitness -- Health aspects, AIDS vaccines -- Health aspects, HIV infection -- Prevention, News, opinion and commentary
Abstract

Byline: Bashar Abubakar HIV is no longer the death sentence it used to be. Today, more people living with HIV have access to life-saving treatment and can stay healthy by [...]

Published
2022

43. New Data from Queensland University of Technology Illuminate Findings in HIV/AIDS (Primary Oral Vaccination Followed By a Vaginal Pull Protects Mice Against Genital Hsv-2 Infection)

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Vaccination -- Health aspects, Infection -- Health aspects, AIDS vaccines -- Health aspects, HIV infection -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2023 JAN 23 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Investigators discuss new findings in Immune System Diseases and Conditions - HIV/AIDS. According to [...]

Published
2023

44. Global mRNA Therapeutics Market Report 2022 to 2030 - Size, Share & Trends Analysis - ResearchAndMarkets.com

Subjects
BioNTech SE, CureVac N.V., Biotechnology industry -- Industry forecasts, Messenger RNA -- Health aspects, AIDS (Disease) -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2022 DEC 26 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- The 'Global mRNA Therapeutics Market Size, Share & Trends Analysis Report by Application (Infectious [...]

Published
2022

45. Researchers at Sanofi Target Herpes Simplex Virus (Nonclinical Safety Evaluation of Two Vaccine Candidates for Herpes Simplex Virus Type 2 To Support Combined Administration In Humans)

Subjects
World health -- Health aspects, Herpes simplex -- Health aspects, Herpes simplex virus -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2022 DEC 19 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Investigators publish new report on Herpesvirus Diseases and Conditions - Herpes Simplex Virus. According [...]

Published
2022

46. How antibody therapy impacts COVID vaccines

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Biopharmaceutics -- Health aspects, B cells -- Health aspects, RNA -- Health aspects, AIDS (Disease) -- Health aspects, Monoclonal antibodies -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2022 DEC 19 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Nearly three years into the pandemic, many of us now carry antibodies against the [...]

Published
2022

47. Attenuated humoral responses in HIV infection after SARS-CoV-2 vaccination are linked to global B cell defects and cellular immune profiles

Subjects
HIV (Viruses) -- Health aspects, Vaccination -- Health aspects, Highly active antiretroviral therapy -- Health aspects, B cells -- Health aspects, AIDS (Disease) -- Health aspects, AIDS vaccines -- Health aspects, HIV infection -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2022 NOV 28 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2022

48. Three University of Maryland School of Medicine faculty members honored by Baltimore Business Journal

Subjects
AIDS (Disease) -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology, University of Maryland, Baltimore. School of Medicine
Abstract

2022 NOV 14 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Three University of Maryland School of Medicine (UMSOM) physician researchers were recognized when the [...]

Published
2022

50. 'We're on a mission': the Texas firefighters who will bring a Covid vaccine to your door; As Corpus Christi's emergency rooms fill with unvaccinated patients, the fire department is doing everything it can to prevent new infections

Subjects
Vaccination -- Health aspects, Fire-departments -- Health aspects, Hospitals -- Emergency service, Fire fighters -- Health aspects, AIDS vaccines -- Health aspects, News, opinion and commentary
Abstract

Byline: Alexandra Villarreal in Corpus Christi, Texas Raul Valenzuela sat inside his living room in Corpus Christi, Texas, as two firefighters prepared him for a Covid-19 vaccine. Largely homebound, Valenzuela [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results